Join us for an insightful symposium exploring cutting-edge innovations in oncology and translational research. This event brings together leading experts to discuss breakthroughs in therapeutic strategies, novel biologics, and advanced preclinical models. Key topics include:
- Humanised Models for Drug Development: Addressing challenges in using humanised mice for testing multi-specific biologics and improving translational predictability.
- Next-Generation Immunotherapies: Introducing conditionally-activated T-cell engagers (TCEs) designed to enhance safety while unlocking efficacy in solid tumours.
- Targeting Complex Cancer Drivers: Novel approaches for therapeutic targeting of ecDNA-driven cancers and innovative antibody-drug conjugates (ADCs) for acute myeloid leukaemia.
- Advancing Immuno-Oncology: How a next-generation anti-CCR8 antibody therapeutic shaping the future of immuno-oncology.
- Radiopharmaceutical Development: Building robust programmes using clinically relevant patient-derived xenograft (PDX) models.
- Innovative ADC Strategies: Sigvotatug vedotin, an integrin β6-directed ADC, demonstrating potent antitumour activity and combination potential with targeted therapies.
This symposium offers a unique opportunity to explore transformative science and foster collaboration towards next-generation cancer treatments.
Reserve Your Spot Now!
.jpg?width=401&height=432&name=Rajesh-pic%20(1).jpg)
